Bieżący numer
Archiwum
Online first
O czasopiśmie
Redakcja
Rada Naukowa
Wydawca
Standardy etyczne i procedury
Bazy indeksacyjne
Recenzenci
Recenzenci Honorowi
Prenumerata
Kontakt
Najczęściej czytane artykuły
Dla autorów
Opłata za przetwarzanie artykułu (APC)
Książki i Konferencje
Książki
Konferencje
SARS CoV-2/COVID-19
PRACA PRZEGLĄDOWA
Beyond conventional care: exploring complementary and alternative medicine for autoimmune disorders
1
Faculty of Medicine and Medical Sciences, University of Balamand, Lebanon
2
Faculty of Medicine, Saint Joseph University, Beirut, Lebanon
3
Department of Family Medicine, American University of Beirut, Lebanon
4
Lupus Clinic, Clemenceau Medical Center affiliated with Johns Hopkins Medicine International, Beirut, Lebanon
Data nadesłania: 10-07-2024
Data ostatniej rewizji: 12-10-2024
Data akceptacji: 21-10-2024
Data publikacji online: 11-02-2025
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
This literature review provides a comprehensive overview of the use of complementary and alternative modalities for the treatment of autoimmune diseases, which pose a significant challenge in contemporary healthcare, often requiring long-term management with conventional therapies. It explores a diverse range of complementary and alternative therapies, including herbal remedies, dietary interventions, mind-body practices, and emerging therapies, in the context of the management of several autoimmune diseases, highlighting increased patient satisfaction, pain management and adaptation. The findings shed light on the evolving role of complementary and alternative medicine in addressing autoimmune diseases, emphasizing the importance of a holistic approach to patient care.
REFERENCJE (88)
1.
Kocyigit BF, Sagtaganov Z, Yessirkepov M, Akyol A. Assessment of complementary and alternative medicine methods in the management of ankylosing spondylitis, rheumatoid arthritis, and fibromyalgia syndrome. Rheumatol Int 2023; 43: 617–625, DOI: 10.1007/s00296-022-05267-1.
2.
Kocyigit BF, Sagtaganov Z, Yessirkepov M. The effectiveness of yoga as a form of exercise in the management of rheumatic diseases. Rheumatol Int 2023; 43: 795–801, DOI: 10.1007/s00296-023-05291-9.
3.
Pagán JA, Pauly MV. Access to conventional medical care and the use of complementary and alternative medicine. Health Aff (Millwood) 2005; 24: 255–262, DOI: 10.1377/hlthaff.24.1.255.
4.
Wang L, Wang F-S, Gershwin ME. Human autoimmune diseases: a comprehensive update. Journal of Internal Medicine 2015; 278: 369–395, DOI: 10.1111/joim.12395.
5.
Floreani A, Franceschet I, Cazzagon N, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 2015; 48: 192–197, DOI: 10.1007/s12016-014-8427-x.
6.
Gulati M, Farah Z, Mouyis M. Clinical features of rheumatoid arthritis. Medicine 2018; 46: 211–215, DOI: 10.1016/j.mpmed. 2018.01.008.
7.
Nicola AA, Dună M, Miler I, et al. Systemic lupus erythematosus with multiple organ damage. Internal Medicine 2020; 17: 63–73, DOI: 10.2478/inmed-2020-0135.
8.
Ameer MA, Chaudhry H, Mushtaq J, et al. An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus 2022; 14: e30330, DOI: 10.7759/ cureus.30330.
9.
Durcan L, O’Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 2019; 393: 2332–2343, DOI: 10.1016/S0140-6736(19)30237-5.
10.
Wang M, Liu W, Ge J, Liu S. The immunomodulatory mechanisms for acupuncture practice. Front Immunol 2023; 14: 1147718, DOI: 10.3389/fimmu.2023.1147718.
11.
Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain 2018; 19: 455–474, DOI: 10.1016/j.jpain.2017.11.005.
12.
Greco CM, Nakajima C, Manzi S. Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus. Curr Rheumatol Rep 2013; 15: 378, DOI: 10.1007/s11926-013-0378-3.
13.
Wang H, Wang B, Huang J, et al. Efficacy and safety of acupuncture therapy combined with conventional pharmacotherapy in the treatment of systemic lupus erythematosus: a systematic review and meta-analysis. Medicine (Baltimore) 2023; 102: e35418, DOI: 10.1097/MD.0000000000035418.
14.
Greco CM, Rudy TE, Manzi S. Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial. Arthritis Rheum 2004; 51: 625–634, DOI: 10.1002/art.20533.
15.
Aranow C. Vitamin D and the immune system. J Investig Med 2011; 59: 881–886, DOI: 10.2310/JIM.0b013e31821b8755.
16.
Kamen DL. Vitamin D in lupus – new kid on the block? Bull NYU Hosp Jt Dis 2010; 68: 218–222.
17.
Jiao H, Acar G, Robinson GA, et al. Diet and systemic lupus erythematosus (SLE): from supplementation to intervention. Int J Environ Res Public Health 2022; 19: 11895, DOI: 10.3390/ijerph191911895.
18.
Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients 2010; 2: 355–374, DOI: 10.3390/nu2030355.
19.
Bello KJ, Fang H, Fazeli P, et al. Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus. Rheumatol Int 2013; 33: 2789–2796, DOI: 10.1007/s00296- 013-2811-3.
20.
Githaiga FM, Omwenga GI, Ngugi MP. In vivo ameliorative effects of vitamin E against hydralazine-induced lupus. Lupus Sci Med 2023; 10: e001033, DOI: 10.1136/lupus-2023-001033.
21.
Chauhan K, Jandu JS, Brent LH, Al-Dhahir MA. Rheumatoid arthritis. StatPearls Publishing LLC, Treasure Island (FL) 2024.
22.
Gualberto Cardoso PR, Diniz Lopes Marques C, de Melo Vilar K, et al. Interleukin-18 in Brazilian rheumatoid arthritis patients: can leflunomide reduce it? Autoimmune Dis 2021; 2021: 6672987, DOI: 10.1155/2021/6672987.
23.
Sakamoto A, Saotome M, Iguchi K, Maekawa Y. Marine-derived omega-3 polyunsaturated fatty acids and heart failure: current understanding for basic to clinical relevance. Int J Mol Sci 2019; 20: 4025, DOI: 10.3390/ijms20164025.
24.
Efthimiou P, Kukar M. Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities. Rheumatol Int 2010; 30: 571–586, DOI: 10.1007/s00296-009-1206-y.
25.
Jaswal S, Mehta HC, Sood AK, Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003; 338: 123–129, DOI: 10.1016/j.cccn.2003.08.011.
26.
Yatham P, Chintamaneni S, Stumbar S. Lessons from India: a narrative review of integrating yoga within the US healthcare system. Cureus 2023; 15: e43466, DOI: 10.7759/cureus.43466.
27.
Gupta S, Gautam S, Kumar U, et al. Potential role of yoga intervention in the management of chronic non-malignant pain. Evid Based Complement Alternat Med 2022; 2022: 5448671, DOI: 10.1155/2022/5448671.
28.
Moonaz SH, Bingham CO 3rd, Wissow L, Bartlett SJ. Yoga in sedentary adults with arthritis: effects of a randomized controlled pragmatic trial. J Rheumatol 2015; 42: 1194–1202, DOI: 10.3899/jrheum.141129.
29.
Akyuz G, Kenis-Coskun O. The efficacy of tai chi and yoga in rheumatoid arthritis and spondyloarthropathies: a narrative biomedical review. Rheumatol Int 2018; 38: 321–330, DOI: 10.1007/ s00296-017-3867-2.
30.
Benson H, Beary JF, Carol MP. The relaxation response. Psychiatry 1974; 37: 37–46, DOI: 10.1080/00332747.1974.11023785.
31.
Barsky AJ, Ahern DK, Orav EJ, et al. A randomized trial of three psychosocial treatments for the symptoms of rheumatoid arthritis. Semin Arthritis Rheum 2010; 40 222–232, DOI: 10.1016/ j.semarthrit.2010.04.001.
32.
Ocampo DV, Gladman D. Psoriatic arthritis. F1000Res 2019; 8, DOI: 10.12688/f1000research.19144.1.
33.
Fitzgerald K, Hyman M, Swift K. Psoriatic arthritis. Glob Adv Health Med 2012; 1: 54–61, DOI: 10.7453/gahmj.2012.1.4.009.
34.
Roberts JAt, Mandl LA. Complementary and alternative medicine use in psoriatic arthritis patients: a review. Curr Rheumatol Rep 2020; 22: 81, DOI: 10.1007/s11926-020-00956-x.
35.
Adawi M, Damiani G, Bragazzi NL, et al. The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study. Nutrients 2019; 11: 601, DOI: 10.3390/nu11030601.
36.
Ford AR, Siegel M, Bagel J, et al. Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review. JAMA Dermatol 2018; 154: 934–950, DOI: 10.1001/jamadermatol.2018.1412.
37.
Odonwodo A, Badri T, Hariz A. Scleroderma. StatPearls. StatPearls Publishing LLC, Treasure Island (FL) 2024.
38.
Liu XS, Gao Y, Zheng LW, Hua H. New alternative therapy for orofacial localized scleroderma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110: e15–e19, DOI: 10.1016/ j.tripleo.2010.04.004 .
39.
Wu R, Zhou Y, Xu H, et al. Aqueous extract of Salvia miltiorrhiza Bunge reduces blood pressure through inhibiting oxidative stress, inflammation and fibrosis of adventitia in primary hypertension. Front Pharmacol 2023; 14: 1093669, DOI: 10.3389/fphar.2023.1093669.
40.
Arribas-López E, Zand N, Ojo O, et al. A Systematic Review of the Effect of Centella asiatica on Wound Healing. Int J Environ Res Public Health 2022; 19: 3266, DOI: 10.3390/ijerph- 19063266.
41.
Cao YL, Li X, Zheng M. Capparis spinosa protects against oxidative stress in systemic sclerosis dermal fibroblasts. Arch Dermatol Res 2010; 302: 349–355, DOI: 10.1007/s00403-009-0998-7.
42.
Assar S, Khazaei H, Naseri M, et al. Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment. J Immunol Res 2021; 2021: 9920416, DOI: 10.1155/2021/ 9920416.
43.
Lee WR, Kim SJ, Park JH, et al. Bee venom reduces atherosclerotic lesion formation via anti-inflammatory mechanism. Am J Chin Med 2010; 38: 1077–1092, DOI: 10.1142/S0192415X10008482.
44.
Thangapazham RL, Sharma A, Maheshwari RK. Beneficial role of curcumin in skin diseases. Adv Exp Med Biol 2007; 595: 343–357, DOI: 10.1007/978-0-387-46401-5_15.
45.
Furgiuele A, Cosentino M, Ferrari M, Marino F. Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review. J Neuroimmune Pharmacol 2021; 16: 251–269, DOI: 10.1007/s11481-021-09982-7.
46.
Serafimovska T. Approved indications for cannabis-based preparations. IOSR Journal of Pharmacy 2021; 11: 2319–4219.
47.
Poole JL. Musculoskeletal rehabilitation in the person with scleroderma. Curr Opin Rheumatol 2010; 22: 205–212, DOI: 10.1097/BOR.0b013e328335a7d2.
48.
Pirrello R, Verro B, Grasso G, et al. Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study. Arthritis Res Ther 2019; 21: 286, DOI: 10.1186/s13075-019-2062-0.
49.
Malek N, Starowicz K. Joint problems arising from lack of repair mechanisms: can cannabinoids help? Br J Pharmacol 2019; 176: 1412–1420, DOI: 10.1111/bph.14204.
50.
Cui A, Li H, Wang D, et al. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population- based studies. EClinicalMedicine 2020; 29–30: 100587, DOI: 10.1016/j.eclinm.2020.100587.
51.
Johal H, Vannabouathong C, Chang Y, et al. Medical cannabis for orthopaedic patients with chronic musculoskeletal pain: does evidence support its use? Ther Adv Musculoskelet Dis 2020; 12: 1759720x20937968, DOI: 10.1177/1759720X20937968.
52.
Renslo B, Greis A, Liu CS, et al. Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis. Cureus 2022; 14: e21564, DOI: 10.7759/cureus.21564.
53.
Dunn SL, Wilkinson JM, Crawford A, et al. Expression of Cannabinoid Receptors in Human Osteoarthritic Cartilage: Implications for Future Therapies. Cannabis Cannabinoid Res 2016; 1: 3–15, DOI: 10.1089/can.2015.0001.
54.
Mlost J, Kędziora M, Starowicz K. Computational Approach Reveals Pronociceptive Potential of Cannabidiol in Osteoarthritis: Role of Transient Receptor Potential Channels. Pharmaceuticals 2021; 14: 964, DOI: 10.3390/ph14100964.
55.
Chiranthanut N, Hanprasertpong N, Teekachunhatean S. Thai massage, and Thai herbal compress versus oral ibuprofen in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. Biomed Res Int 2014; 2014: 490512, DOI: 10.1155/2014/490512.
56.
Moyer CA, Rounds J, Hannum JW. A meta-analysis of massage therapy research. Psychol Bull 2004; 130: 3–18, DOI: 10.1037/ 0033-2909.130.1.3.
57.
Rabini A, Piazzini DB, Tancredi G, et al. Deep heating therapy via microwave diathermy relieves pain and improves physical function in patients with knee osteoarthritis: a double-blind randomized clinical trial. Eur J Phys Rehabil Med 2012; 48: 549–559.
58.
Witt CM, Jena S, Brinkhaus B, et al. Acupuncture in patients with osteoarthritis of the knee or hip: a randomized, controlled trial with an additional nonrandomized arm. Arthritis Rheum 2006; 54: 3485–3493, DOI: 10.1002/art.22154.
59.
Scharf HP, Mansmann U, Streitberger K, et al. Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann Intern Med 2006; 145: 12–20, DOI: 10.7326/0003-4819-145-1-200607040-00005.
60.
Manheimer E, Cheng K, Linde K, et al. Acupuncture for peripheral joint osteoarthritis. Cochrane Database Syst Rev 2010: 2010: CD001977, DOI: 10.1002/14651858.CD001977.pub2.
61.
Lan C, Chen SY, Lai JS, Wong AM. Tai chi chuan in medicine and health promotion. Evid Based Complement Alternat Med 2013; 2013: 502131, DOI: 10.1155/2013/502131.
62.
Hartman CA, Manos TM, Winter C, et al. Effects of T’ai Chi training on function and quality of life indicators in older adults with osteoarthritis. J Am Geriatr Soc 2000; 48: 1553–1559, DOI: 10.1111/j.1532-5415.2000.tb03863.x.
63.
Wang C, Schmid CH, Hibberd PL, et al. Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial. Arthritis Rheum 2009; 61: 1545–1553, DOI: 10.1002/art.24832.
64.
Song R, Roberts BL, Lee EO, et al. A randomized study of the effects of t’ai chi on muscle strength, bone mineral density, and fear of falling in women with osteoarthritis. J Altern Complement Med 2010; 16: 227–233, DOI: 10.1089/acm.2009.0165.
65.
Ahmed S, Anuntiyo J, Malemud CJ, Haqqi TM. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid Based Complement Alternat Med 2005; 2: 301–308, DOI: 10.1093/ecam/neh117.
66.
Niggemann B, Grüber C. Side-effects of complementary and alternative medicine. Allergy 2003; 58: 707–716, DOI: 10.1034/ j.1398-9995.2003.00219.x.
67.
Bensoussan A, Myers SP, Carlton AL. Risks associated with the practice of traditional Chinese medicine: an Australian study. Arch Fam Med 2000; 9: 1071–1078, DOI: 10.1001/archfami.9.10.1071.
68.
Mazal DA, King T, Harvey J, Cohen J. Bilateral pneumothorax after acupuncture. N Engl J Med 1980; 302: 1365–1366, DOI: 10.1056/NEJM198006123022416.
69.
Wright RS, Kupperman JL, Liebhaber MI. Bilateral tension pneumothoraces after acupuncture. West J Med 1991; 154: 102–103.
70.
Kirchgatterer A, Schwarz CD, Höller E, et al. Cardiac tamponade following acupuncture. Chest 2000; 117: 1510–1511, DOI: 10.1378/chest.117.5.1510.
71.
Hasegawa J, Noguchi N, Yamasaki J, et al. Delayed cardiac tamponade and hemothorax induced by an acupuncture needle. Cardiology 1991; 78: 58–63, DOI: 10.1159/000174766.
72.
Peuker ET, White A, Ernst E, et al. Traumatic complications of acupuncture. Therapists need to know human anatomy. Arch Fam Med 1999; 8: 553–558, DOI: 10.1001/archfami.8.6.553.
73.
Odsberg A, Schill U, Haker E. Acupuncture treatment: side effects and complications reported by Swedish physiotherapists. Complement Ther Med 2001; 9: 17–20, DOI: 10.1054/ctim. 2000.0418.
74.
Rampes H, James R. Complications of acupuncture. Acupunct Med 1995; 13: 26–33, DOI: 10.1136/aim.13.1.26.
75.
Izatt E, Fairman M. Staphylococcal septicaemia with disseminated intravascular coagulation associated with acupuncture. Postgrad Med J 1977; 53: 285–286, DOI: 10.1136/pgmj. 53.619.285.
76.
Scheel O, Sundsfjord A, Lunde P, Andersen BM. Endocarditis after acupuncture and injection – treatment by a natural healer. JAMA 1992; 267: 56, DOI: 10.1001/jama.267.1.56b.
77.
Vittecoq D, Mettetal JF, Rouzioux C, et al. Acute HIV infection after acupuncture treatments. N Engl J Med 1989; 320: 250–251, DOI: 10.1056/NEJM198901263200413.
78.
Bateman J, Chapman RD, Simpson D. Possible toxicity of herbal remedies. Scott Med J 1998; 43: 7–15, DOI: 10.1177/00369 3309804300104.
79.
Wang Z, Hamman MA, Huang SM, et al. Effect of St John’s wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002; 71: 414–420, DOI: 10.1067/mcp.2002.124080.
80.
Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355: 134–138, DOI: 10.1016/S0140-6736(99)06457-0.
81.
Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am Fam Physician 1999; 59: 1239–1245.
82.
Ahmed MT, Loutfy N, Yousef Y. Contamination of medicinal herbs with organophosphorus insecticides. Bull Environ Contam Toxicol 2001; 66: 421–426, DOI: 10.1007/s001280022.
83.
Kew J, Morris C, Aihie A, et al. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 1993; 306: 506–507, DOI: 10.1136/bmj.306.6876.506.
84.
Itoh S, Marutani K, Nishijima T, et al. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995; 40: 1845–1848, DOI: 10.1007/BF02212712.
85.
Kamiyama T, Nouchi T, Kojima S, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997; 92: 703–704.
86.
Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 1994; 24: 172–180, DOI: 10.1016/S0272-6386(12)80178-8.
87.
Ferguson JE, Chalmers RJ, Rowlands DJ. Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol 1997; 136: 592–593, DOI: 10.1046/j.1365-2133.1997.d01-1241.x.
88.
Ng TH, Chan YW, Yu YL, et al. Encephalopathy and neuropathy following ingestion of a Chinese herbal broth containing podophyllin. J Neurol Sci 1991; 101: 107–113, DOI: 10.1016/0022-510X(91)90024-2.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Udostępnij
ARTYKUŁ POWIĄZANY
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
Przetwarzamy dane osobowe zbierane podczas odwiedzania serwisu. Realizacja funkcji pozyskiwania informacji o użytkownikach i ich zachowaniu odbywa się poprzez dobrowolnie wprowadzone w formularzach informacje oraz zapisywanie w urządzeniach końcowych plików cookies (tzw. ciasteczka). Dane, w tym pliki cookies, wykorzystywane są w celu realizacji usług, zapewnienia wygodnego korzystania ze strony oraz w celu monitorowania ruchu zgodnie z Polityką prywatności. Dane są także zbierane i przetwarzane przez narzędzie Google Analytics (więcej).
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
Możesz zmienić ustawienia cookies w swojej przeglądarce. Ograniczenie stosowania plików cookies w konfiguracji przeglądarki może wpłynąć na niektóre funkcjonalności dostępne na stronie.
